Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

92.95 +2.21 (+2.44%)
Streaming Delayed Price Updated: 10:08 AM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
News headline image
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗
All three ETFs complement each other well in a portfolio. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market. 
Via The Motley Fool
Topics Intellectual Property
News headline image
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000 ↗
Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot. 
Via The Motley Fool
Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullback ↗
Via Chartmill
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
These healthcare stocks may be the building blocks of a winning portfolio. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16? ↗
July earnings matter, but long-term growth matters more. 
Via The Motley Fool
News headline image
3 High-Yield Dividend Stocks to Buy Hand Over Fist in June ↗
Now's the time to load up on these high-yielders. 
Via The Motley Fool
Topics Economy
News headline image
Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months ↗
Analysts remain relatively more upbeat, but this could prove fleeting. 
Via The Motley Fool
News headline image
New Investors: 3 Rock-Solid Stocks to Build Your Portfolio Around ↗
Visa, Home Depot, and Abbott Laboratories are blue chip stocks that can provide your portfolio with a good mix of safety, stability, and dividend income over the long term. 
Via The Motley Fool
Topics Credit Cards Economy
News headline image
Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis? ↗
Declining sales of plant-based meats have the company looking for other revenue sources. 
Via The Motley Fool
News headline image
Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗
Grail is on a quest to win in a $50 billion market. 
Via The Motley Fool
News headline image
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500? ↗
For a solid yield and strong upside potential, this pharmaceutical stock is worth considering. 
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
This particular sector may suit cautious and aggressive investors. 
Via The Motley Fool
News headline image
3 Beaten-Down Stocks to Buy and Hold Forever ↗
Don't wait too long to buy the dip on these stocks. 
Via The Motley Fool
Topics World Trade
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
3 Monster Dividend Stocks to Hold for the Next 10 Years ↗
These stocks are built for the long haul. And they pay great dividends. 
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market ↗
This big pharma stock checks off a lot of boxes. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
3 Stocks to Buy if You Think the Economy Is Heading for a Recession ↗
They have increased their payouts for a combined 171 years straight. 
Via The Motley Fool
Topics Economy
News headline image
Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell ↗
See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
This Dividend ETF May Be the Ultimate Income Investment to Put in Your Portfolio Right Now ↗
The Schwab U.S. Dividend Equity ETF checks off all the key boxes investors are likely going to want from a top dividend investment. 
Via The Motley Fool
Topics ETFs
News headline image
Sell in May and Go Away—Starting With These 3 Stocks ↗
Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk ↗
This mortgage REIT generates income by originating and managing commercial real estate loans across the United States. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress ↗
Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends. 
Via The Motley Fool
News headline image
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗
They have combined for 118 years of consecutive dividend increases. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lows ↗
These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market. 
Via The Motley Fool
Topics Economy Stocks
News headline image
Want Reliable Dividend Income in May? These 2 Stocks Deliver ↗
These stocks check off multiple boxes for income investors. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy? ↗
A rare yield, Dividend King status, and a steady healthcare business may be creating one of its most interesting income setups in years. 
Via The Motley Fool
News headline image
1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever ↗
This company, which has raised its dividend for 54 consecutive years, is on sale. 
Via The Motley Fool
News headline image
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? ↗
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.